PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度募集资金存放、管理与使用情况的专项报告 | 2026-04-21 | Chinese | |
| 关于2026年度开展外汇衍生品交易预计及授权的公告 | 2026-04-21 | Chinese | |
| 第四届董事会第十三次会议决议公告 | 2026-04-21 | Chinese | |
| 2026年一季度报告 | 2026-04-21 | Chinese | |
| 非经营性资金占用及其他关联资金往来情况汇总表的专项说明 | 2026-04-21 | Chinese | |
| 非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40025117 | 2025年度募集资金存放、管理与使用情况的专项报告 | 2026-04-21 | Chinese | ||
| 40025115 | 关于2026年度开展外汇衍生品交易预计及授权的公告 | 2026-04-21 | Chinese | ||
| 40025114 | 第四届董事会第十三次会议决议公告 | 2026-04-21 | Chinese | ||
| 40025112 | 2026年一季度报告 | 2026-04-21 | Chinese | ||
| 40025110 | 非经营性资金占用及其他关联资金往来情况汇总表的专项说明 | 2026-04-21 | Chinese | ||
| 40025107 | 非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-21 | Chinese | ||
| 40025105 | 2025年年度审计报告 | 2026-04-21 | Chinese | ||
| 40025102 | 2025年年度报告 | 2026-04-21 | Chinese | ||
| 40025096 | 南京药石科技股份有限公司2025年年度财务报告 | 2026-04-21 | Chinese | ||
| 40025094 | 2025年年度报告摘要 | 2026-04-21 | Chinese | ||
| 40025091 | 关于2022年限制性股票激励计划作废部分已授予但尚未归属的限制性股票的公告 | 2026-04-21 | Chinese | ||
| 40025089 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司2025年度募集资金存放与实际使用情况的核查意见 | 2026-04-21 | Chinese | ||
| 40025087 | 董事会审计委员会2025年度履职报告 | 2026-04-21 | Chinese | ||
| 40025085 | 2025年度内部控制自我评价报告 | 2026-04-21 | Chinese | ||
| 40025081 | 关于变更公司经营范围、修订《公司章程》暨授权办理工商变更登记的公告 | 2026-04-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.